GlassScriptPhysician profile
Robert Craig Burt
NPI 1346804374
$3,911.02
in general payments reported to CMS, 2019-2025
7 companies · $3,776 in 2025
The $3,776 reported for 2025 was more than what 83% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $135 · 2025: $3,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,213 · Travel and Lodging: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,212.73 |
| Travel and Lodging | $1,698.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $1,235.05 | 2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Terumo Medical Corporation | $1,007.72 | 2025 | Glidewire, Azur Cx Detachable |
| Stryker Corporation | $652.10 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Boston Scientific Corporation | $338.49 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Embold Fibered, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Cook Medical LLC | $275.96 | 2025 | Rosch-Uchida |
| Penumbra, INC. | $266.70 | 2025 | Indigo System |
| Trisalus Life Sciences, INC. | $135.00 | 2024 | Trinav Infusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Burt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.